Business Combinations (Tables)

3 Months Ended

Dec. 31, 2015

The purchase price of Creagh Medical consisted of the following:

(Dollars in thousands)
Cash paid	$	18,417
Debt assumed		793
Contingent consideration		9,064
Total purchase price		28,274
Less cash and cash equivalents acquired		(251	)
Total purchase price, net of cash acquired	$	28,023

Schedule of Purchase Price to the Fair Values Assigned to the Assets Acquired and Liabilities Assumed

The following table summarizes the preliminary allocation of the purchase price to the fair values assigned to the assets acquired and the liabilities assumed at the date of the Creagh Medical acquisition:

	Fair Value (Dollars in thousands)			Estimated Useful Life (In years)
Current assets	$	708		N/A
Property and equipment		634		1.0-10.0
Trade name		75		N/A
Developed technology		1,787		7.0
In-process research and development		942		N/A
Customer relationships		11,119		7.0-10.0
Other noncurrent assets		81		N/A
Current liabilities		(923	)	N/A
Deferred tax liabilities		(9	)	N/A
Net assets acquired		14,414
Goodwill		13,609		N/A
Total purchase price, net of cash acquired	$	28,023

NorMedix, Inc. [Member]

Business Acquisition [Line Items]

Summary of Purchase Price

The purchase price of NorMedix consisted of the following:

(Dollars in thousands)
Cash paid	$	7,000
Contingent consideration		3,740
Total purchase price		10,740
Less cash and cash equivalents acquired		(17	)
Total purchase price, net of cash acquired	$	10,723

Schedule of Purchase Price to the Fair Values Assigned to the Assets Acquired and Liabilities Assumed

The following table summarizes the allocation of the preliminary purchase price to the fair values assigned to the assets acquired and the liabilities assumed at the date of the NorMedix acquisition:

	Fair Value (Dollars in thousands)			Estimated Useful Life (In years)
Net current assets	$	46		N/A
Property and equipment		76		N/A
Developed technology		6,850		10.0-14.0
Customer relationships		900		4.0
Deferred tax asset		544		N/A
Other noncurrent asset		12		N/A
Deferred tax liabilities		(2,474	)	N/A
Net assets acquired		5,954
Goodwill		4,769		N/A
Total purchase price, net of cash acquired	$	10,723

Creagh Medical and NorMedix [Member]

Business Acquisition [Line Items]

Schedule of Pro Forma Financial Information

		Three Months Ended
		December 31,
		2015		2014
(In thousands, except per share data)	(Unaudited)
Revenue		$	17,643	$	14,796
Net income		$	4,189	$	2,263

Per share amounts:
Basic net income per share		$	0.32	$	0.17
Diluted net income per share		$	0.32	$	0.17